Soy-Based Infant Formula Market Size, Growth, and Forecast Insights

Soy-Based Infant Formula market was valued at $XX Billion in 2021 and is expected to reach $XX Billion by 2029, growing at a CAGR of around 7.63% during the forecast period. The global Soy-Based Infant Formula market growth is mainly attributed to the factors such as increasing number of mothers with low breast milk production, rising awareness among consumers regarding safety, brands, and nutrition, and the development of organic baby food, including soy infant formula. Additionally, soy-based infant formula requirements are expected to rise because these products are readily available and suitable for lactose-intolerant infants. Despite these drivers, the risks associated with the high consumption of soy-based infant formula is a major restraint hampering the market growth. Moreover, increasing R&D activities, growing focus on infant care & nutrition, and shifting focus towards clean label & plant-based products are offering profitable opportunities to the market growth in the upcoming years.

Introduction:

Soy-based infant formula substitutes human breast milk or cow milk, using soy protein and other components. It uses processed soybeans as a source of protein, and it has been formulated in the form of liquid or powder. Soy-based infant formula contains different sugar groups, excluding lactose; other ingredients are naturally occurring plant-based compounds like phytic acid. It differs from human breast milk in multiple ways, including inhibition of iron absorption, though it can be removed in processing.

COVID-19 Impact on Soy-Based Infant Formula Market:

In 2020, during the COVID-19 pandemic, there have been unprecedented variations in the global sales of infant formula and food products due to rapid changes in consumer purchase patterns. The increasing trend of bulk buying and stockpiling of infant formula has led to certain products being in minimal supply, which has led to price fluctuations in the global infant formula market. By 2022, the COVID-19 pandemic could result in an additional 11.9 million severely malnourished children and 168,000 child deaths. So, it is essential to prioritize nutrition interventions, especially breastfeeding. The key players in the market are taking advantage of the COVID-19 pandemic to promote the outlook of baby formula, saying COVID-19 can transmit through breastfeeding. Predatory marketing of breast-milk substitutes creates a significant barrier to breastfeeding across the globe.

Global Soy-Based Infant Formula Market Segments Share:

The global Soy-Based Infant Formula market is segregated on the basis of product type, age group, and geography. According to different studies & preventive measures, it is recommended that the soy-based infant formula usage at the first-line treatment should be reduced/discouraged during the first six months of the newborn. Because the infants receiving soy-based infant formula as a sole source of nutrition for 0-6 months will consume between 6-12 mg isoflavones per kg body weight/day. The significant permanent changes due to phytoestrogens are most likely to happen during the 4-6 months developmental stage. Some infants with lactose intolerant may also be sensitized to soy protein, particularly below six months. The prevalence of concomitant soy allergy in infants with cow’s milk allergy varies between Immunoglobulin (IgE) and non-IgE mediated disease. Soy-based infant formula is not recommended before six months in children with food allergies.

Based on geography, the market is categorized into North America, South America, Europe, Asia Pacific, and Middle East & Africa. Among these, North America region is estimated to hold the significant market share during the forecast period. Amongst North American countries, the U.S. holds a significant market share in the overall market during the forecast period due to innovations in products and technologies. Over the past few years, Soy-based infant formulas have been used in the U.S. The major factors responsible for the market growth include the rising participation of women in the labour force, changing lifestyle of the middle-class population due to rapid urbanization and increasing disposable income. For example, the U.S. Bureau of Statistics states that the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Also, it is perceived that baby infant formula are rich in nutrients and supplements the growth of the baby and growing health consciousness among the consumers in the U.S. are boosting the infant formula demand.

Global Soy-Based Infant Formula Market Trends:

• In August 2021, Omega-3 DHA innovator Martek Biosciences Corporation and The Hain Celestial Group, Inc., a leading natural and organic food and personal care products company, announced today that they have entered into a license and supply agreement whereby Martek will serve as the exclusive DHA and ARA supplier for all Hain Celestial infant formula products in the U.S.
• In June 2021, Reckitt Benckiser Group PLC announced that it as entered into a definitive agreement to sell its infant formula and child nutrition business in China to Primavera Capital Group for a value of $2.2 Billion.

Global Soy-Based Infant Formula Market Research Report Include:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
• Expertise investment opportunities by analyst to the individual and organization to have better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Nestle S.A.
• Abbott Laboratories
• Perrigo Company PLC
• Reckitt Benckiser Group PLC
• The Hain Celestial Group, Inc.

Along with these companies, there were many other companies considered/ cited in the report while analyzing the Soy-Based Infant Formula market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.